CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS

Institutional investor · Portfolio as of Q3 2020

SEC EDGAR SourceSEC Filings

Top Holdings3,308 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

2.2M$252M4.2%$96.98+15.73%
8 qtrssince 2018-Q4
Increased
91

MICROSOFT CORP

1M$215M3.6%$142.76+38.94%
8 qtrssince 2018-Q4
Decreased
0

EMERSON ELECTRIC CO

2.9M$187.9M3.1%$66.33-12.39%
8 qtrssince 2018-Q4
Decreased
0
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

452,613$153.2M2.5%$229.56+34.58%
8 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

43,749$140.9M2.3%$98.70+59.32%
8 qtrssince 2018-Q4
Decreased
0
XLKXLK
ETF

TECHNOLOGY SELECT SECTOR FUND SPDR

1.2M$137.3M2.3%$50.98+8.91%
8 qtrssince 2018-Q4
Increased
75
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

1.2M$126.5M2.1%$92.43+3.28%
8 qtrssince 2018-Q4
Increased
80
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

292,870$99.1M1.6%$244.15+26.64%
8 qtrssince 2018-Q4
Decreased
0

LOWE'S COS INC

446,224$74.6M1.2%$90.29+64.42%
8 qtrssince 2018-Q4
Decreased
0

PROCTER & GAMBLE CO/THE

465,825$64.9M1.1%$91.53+30.35%
8 qtrssince 2018-Q4
Decreased
0

AMGEN INC

249,204$63.6M1.1%$191.51+11.00%
8 qtrssince 2018-Q4
Increased
49
VTIVTI
ETF

VANGUARD TOTAL STOCK MARKET VIPERS

321,289$55.2M0.9%$127.69+22.88%
8 qtrssince 2018-Q4
Decreased
0
VIGVIG
ETF

VANGUARD DIVIDEND APPRECIATION ETF ETF

415,913$54M0.9%$91.01+27.34%
8 qtrssince 2018-Q4
Decreased
0

ADOBE INC

107,912$53.9M0.9%$331.00+48.17%
8 qtrssince 2018-Q4
Decreased
0
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

233,940$51.4M0.9%$40.70+28.79%
8 qtrssince 2018-Q4
Decreased
0

WALMART INC

346,817$49.6M0.8%$35.38+20.25%
8 qtrssince 2018-Q4
Decreased
0

JOHNSON & JOHNSON

330,281$48.7M0.8%$113.00+12.14%
8 qtrssince 2018-Q4
Decreased
0

VERIZON COMMUNICATIONS INC

816,377$48.5M0.8%$41.24+3.54%
8 qtrssince 2018-Q4
Decreased
0

BERKSHIRE HATHAWAY INC-CL B

222,765$47.2M0.8%$197.79+6.40%
8 qtrssince 2018-Q4
Decreased
0

BANK OF AMERICA CORP

2M$47.1M0.8%$27.93-24.86%
8 qtrssince 2018-Q4
Decreased
0
$6B
AUM
3,308
Positions
Q3 2020
Filing
Rating · 5.0
Quarterly Portfolio Change
+10%Q2'19$2.7B+5%Q3'19$2.8B+123%Q4'19$6.3B-28%Q1'20$4.5B+34%Q2'20$6.1B-1%Q3'20$6B
Activity profile
$ moved · Q3'20
New1%Increased40%Decreased57%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 years
<1Q13%1-4Q31%1-2Y56%2Y+0%

CAPTRUST FINANCIAL ADVISORS manages $6B across 3308 positions as of Q3 2020. Top holdings: AAPL (4.2%), MSFT (3.6%), EMR (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 5/5.0.

Q3 2020 Summary

Active quarter - 540 new positions, 284 exits, 1065 increased. Top move: AAPL (INCREASED, conviction 91). Portfolio: $6.0B across 3308 positions.

Top holdings by portfolio weight

Total AUM$6B
AAPL4.18%
MSFT3.57%
EMR3.12%
SPY2.54%
AMZN2.34%
XLK2.28%
XLV2.10%
IVV1.64%
LOW1.24%
PG1.08%
Other1.06%

Portfolio allocation by GICS sector

Sectors11
Unknown33.13%
Technology16.01%
Healthcare10.10%
Industrials9.38%
Financial Services8.57%
Consumer Cyclical7.79%
Consumer Defensive5.84%
Communication Services4.80%
Utilities1.80%
Energy1.57%
Other1.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Elite(5.0 / 5.0)
Track Record60
Conviction41
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ABBVABBVABBVIE INC
Q3 2024 Q2 2026+649,630 shares+$257M
8Q
BCIBCIABRDN ETFS
Q3 2024 Q2 2026+36,409 shares+$867,503
8Q
ADPTADPTAdaptive Biotechnologies Corp.
Q3 2024 Q2 2026+12,146 shares+$462,243
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used